Roberts, Scott J.
Ke, Hua Zhu
Article History
First Online: 3 May 2018
Compliance with Ethical Standards
:
: Scott Roberts is a full time employee for UCB Pharma and owns stock in UCB. Hue Zhu Ke is a full time employee for UCB Pharma and owns stock in UCB and Amgen. Dr. Ke has a patent (‘Method for treating bone fracture with anti-sclerostin antibodies) issued, owned by Amgen.
: This article does not contain any studies with human or animal subjects performed by any of the authors.